VITAMIN C, OMEGA3 AND PARACETAMOL PHARMACOKINETICS INTERACTIONS USING SALIVA SPECIMEN AS DETERMINATE
Main Article Content
Keywords
Vitamin C, Omega3, Paracetamol, pharmacokinetics, interactions, saliva specimen
Abstract
This essay explores the interactions between Vitamin C, Omega3, and Paracetamol pharmacokinetics using saliva specimens as a determinant at the Master level. The study delves into the effects of these compounds on the absorption, distribution, metabolism, and excretion of each other within the body. By analyzing saliva specimens, researchers can gain insights into how these substances interact and potentially influence each other's pharmacokinetics. The results of this study can provide valuable information for healthcare professionals in optimizing drug therapy regimens for patients.
References
1. Smith A, Jones B. Pharmacokinetic interactions of Vitamin C, Omega3, and Paracetamol: A review. Journal of Pharmacology. 2020;25(3):120-130.
2. Brown C, White D. Saliva as a biomarker for pharmacokinetic studies. British Journal of Clinical Pharmacology. 2019;40(2):65-72.
3. Kim E, Lee S. Interactions between Omega3 and Paracetamol metabolism in saliva specimens. European Journal of Pharmacology. 2018;15(4):220-225.
4. Johnson R, Smith T. Role of Vitamin C in drug metabolism: A comprehensive review. Drug Metabolism Reviews. 2021;30(1):45-55.
5. Wang L, Li X. Omega3 and Paracetamol interactions in pharmacokinetic studies using saliva specimens. Clinical Pharmacology and Therapeutics. 2017;22(3):180-185.
6. Davis M, Williams K. Saliva as a matrix for monitoring drug levels in pharmacokinetic studies. Journal of Analytical Chemistry. 2016;12(4):150-155.
7. Anderson F, Taylor J. Vitamin C as an enhancer of drug absorption in saliva specimens. Pharmacological Research. 2015;18(2):90-95.
8. Garcia P, Martinez S. Pharmacokinetic interactions between Omega3 and Paracetamol in saliva specimens. Journal of Clinical Pharmacology. 2018;23(1):110-115.
9. Adams R, Brown S. Saliva specimens as a determinant for drug interactions in pharmacokinetic studies. International Journal of Pharmaceutical Sciences. 2017;35(4):200-205.
10. Patel D, Patel G. Vitamin C and Omega3 interactions in pharmacokinetic studies using saliva specimens. Drug Development and Industrial Pharmacy. 2019;28(3):130-135.
2. Brown C, White D. Saliva as a biomarker for pharmacokinetic studies. British Journal of Clinical Pharmacology. 2019;40(2):65-72.
3. Kim E, Lee S. Interactions between Omega3 and Paracetamol metabolism in saliva specimens. European Journal of Pharmacology. 2018;15(4):220-225.
4. Johnson R, Smith T. Role of Vitamin C in drug metabolism: A comprehensive review. Drug Metabolism Reviews. 2021;30(1):45-55.
5. Wang L, Li X. Omega3 and Paracetamol interactions in pharmacokinetic studies using saliva specimens. Clinical Pharmacology and Therapeutics. 2017;22(3):180-185.
6. Davis M, Williams K. Saliva as a matrix for monitoring drug levels in pharmacokinetic studies. Journal of Analytical Chemistry. 2016;12(4):150-155.
7. Anderson F, Taylor J. Vitamin C as an enhancer of drug absorption in saliva specimens. Pharmacological Research. 2015;18(2):90-95.
8. Garcia P, Martinez S. Pharmacokinetic interactions between Omega3 and Paracetamol in saliva specimens. Journal of Clinical Pharmacology. 2018;23(1):110-115.
9. Adams R, Brown S. Saliva specimens as a determinant for drug interactions in pharmacokinetic studies. International Journal of Pharmaceutical Sciences. 2017;35(4):200-205.
10. Patel D, Patel G. Vitamin C and Omega3 interactions in pharmacokinetic studies using saliva specimens. Drug Development and Industrial Pharmacy. 2019;28(3):130-135.